Related Experiment Video
Updated: Sep 6, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
The emerging role of miR-653 in human cancer
Moussa Omorou1, Yiwei Huang1, Ning Liu1
1Department of Biochemistry and Molecular Biology, Jiamusi University School of Basic Medical Sciences, Jiamusi, Heilongjiang 154000, PR China.
Abstract:
MicroRNAs (miRNAs) refer to a family of non-coding RNA with ~22 nucleotides in length. A high number of studies show evidence that deregulation in miRNAs expression could be implicated in the processes of many pathologies such as cancer, hypoxia, and stroke. Herein, we aimed to summarize the miR-653 expression level and molecular mechanisms through which it functions in human cancer. It was found that variations in miR-653 expression are linked to tumor aggressiveness and unfavorable prognosis in human cancer, and it plays an inhibitory effect in some types of cancer, such as breast, cervical, liver, renal, and lung cancers. In contrast, it plays an acceleratory impact in some other cancers, such as bladder and prostate cancers. In gastric cancer, the role played by miR-653 is still controversial and will need to be elucidated in future studies. Future studies could definitely establish targeting miR-653 as a novel strategy in human cancer, from diagnosis to effective treatment.
Insights
MicroRNA 653 (miR-653) shows varied roles in human cancers, acting as a tumor suppressor in some and a promoter in others. Targeting miR-653 may offer new diagnostic and therapeutic strategies for cancer.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs involved in gene regulation.
- Deregulation of miRNA expression is linked to various pathologies, including cancer, hypoxia, and stroke.
Purpose of the Study:
- To summarize the expression levels and molecular functions of miR-653 in human cancers.
- To investigate the dual role of miR-653 in cancer progression and prognosis.
Main Methods:
- Literature review and analysis of existing studies on miR-653 in human cancer.
- Examination of miR-653 expression patterns and its correlation with tumor aggressiveness and patient outcomes.
Main Results:
- miR-653 expression variations correlate with tumor aggressiveness and prognosis.
- miR-653 acts as a tumor suppressor in breast, cervical, liver, renal, and lung cancers.
- miR-653 acts as an oncogene in bladder and prostate cancers, with a controversial role in gastric cancer.
Conclusions:
- miR-653 exhibits context-dependent roles in human cancer, acting as either an oncogene or tumor suppressor.
- Targeting miR-653 presents a potential novel strategy for cancer diagnosis and treatment.
- Further research is needed to clarify the role of miR-653 in gastric cancer.
Related Concept Videos
MicroRNAs
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mechanisms of Retrovirus-induced Cancers
Mitogens and the Cell Cycle
Abnormal Proliferation
The Tumor Microenvironment

